| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/14/2008 | US20080039491 Substituted pyrazolopyridines, compositions containing them, method for the production thereof, and their use |
| 02/14/2008 | US20080039490 Pyridines for treating injured mammalian nerve tissue |
| 02/14/2008 | US20080039489 Tetrahydrofuran derivatives for use as inhibitors of matrix metalloproteinases |
| 02/14/2008 | US20080039488 Salt of naphthyridine carboxylic acid derivative |
| 02/14/2008 | US20080039487 Processes and intermediates useful for preparing integrase inhibitor compounds |
| 02/14/2008 | US20080039486 Rapamycin analogues; diabetes, acute or chronic rejection of an organ or tissue transplant, asthma, tumours, psoriasis, eczema, rheumatoid arthritis, fibrosis, and allergies |
| 02/14/2008 | US20080039485 Low-dose-long-term pharmaceutical composition comprising camptothecin derivatives for the treatment of cancers |
| 02/14/2008 | US20080039484 Methods and Compositions for Preventing or Treating Cardiovascular Disease |
| 02/14/2008 | US20080039483 Novel Chelidonine Derivatives, Methods for the Production Thereof, and Use Thereof For Producing Pharmaceutical Agents |
| 02/14/2008 | US20080039482 Sulfonamido-macrocycles as tie2 inhibitors and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 02/14/2008 | US20080039480 Quinazolinedione Derivatives as Parp Inhibitors |
| 02/14/2008 | US20080039479 Compounds and therapeutical use thereof |
| 02/14/2008 | US20080039478 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof |
| 02/14/2008 | US20080039477 Pyrazolopyrimidines as Cell Cycle Kinase Inhibitors |
| 02/14/2008 | US20080039476 Pyrazolopyrimidines, a process for their preparation and their use as medicine |
| 02/14/2008 | US20080039475 Compositions and methods for increasing blood platelet levels in humans |
| 02/14/2008 | US20080039474 Novel heterocyclic substituted pyridine compounds with cxcr3 antagonist activity |
| 02/14/2008 | US20080039473 Preparation and utility of substituted quinazoline compounds with alpha-adrenergic blocking effects |
| 02/14/2008 | US20080039472 Inhibitors of the Interaction Between Mdm2 and P53 |
| 02/14/2008 | US20080039471 Composition and method to inhibit tissue plasminogen activator (tPA) - potentiated neurotoxicity |
| 02/14/2008 | US20080039470 Acylaminoheteroaryl hepatitis C virus protease inhibitors |
| 02/14/2008 | US20080039469 3-Benzyl-3a-cyclobutyl-7-methoxymethyl-2-oxo-octahydro-oxazolo[4,5-c]pyridin-5-ium; useful as agents for stimulating the cognitive functions of the brain |
| 02/14/2008 | US20080039468 Novel 3-Phenyltetrahydrocinnolin-5-Ol Derivative and Medicinal Use Thereof |
| 02/14/2008 | US20080039467 Method For The Prevention Of Thromboembolic Disorders |
| 02/14/2008 | US20080039466 2-(3-Substituted-Aryl) Amino-4-Aryl-Thiazoles As Tyrosine Kinase Inhibitors |
| 02/14/2008 | US20080039465 Triazolyl phenyl benzenesulfonamides |
| 02/14/2008 | US20080039464 Compounds Which Modulate The CB2 Receptor |
| 02/14/2008 | US20080039463 Methods and Compositions |
| 02/14/2008 | US20080039462 Compounds having 5-HT6 receptor affinity |
| 02/14/2008 | US20080039461 Treatment of pain by inhibition of p38 map kinase |
| 02/14/2008 | US20080039460 2-Chloro-N-(2-thiophen-2-yl-3H-imidazo[4,5-b]pyridin-6-yl)-benzamide; cancer |
| 02/14/2008 | US20080039459 Phosphoinositide 3-kinase inhibitor compounds and methods of use |
| 02/14/2008 | US20080039458 Substituted pyrazolopyrimidines, a process for their preparation and their use as medicine |
| 02/14/2008 | US20080039457 Triazolotriazines as kinase inhibitors |
| 02/14/2008 | US20080039456 4-[2-(4-nitro-phenyl)-6-oxo-4-thioxo-6H-1-oxa-3b,5-diaza-cyclopenta[a]pentalen-5-yl]-butyric acid, used for inhibiting heparin-binding proteins and in the treatment of pancreatic cancer; anticarcinogenic agents |
| 02/14/2008 | US20080039455 Pyrazolopyrimidines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 02/14/2008 | US20080039454 Urotensin II receptor antagonists |
| 02/14/2008 | US20080039453 Enantiomerically pure R-etifoxine, pharmaceutical compositions thereof and methods of their use |
| 02/14/2008 | US20080039452 Fused Quinoline Derivative and Use Thereof |
| 02/14/2008 | US20080039451 Use of thiazole derivatives for preparing a medicament intended to protect the mitochondria |
| 02/14/2008 | US20080039450 Compounds |
| 02/14/2008 | US20080039449 [1,4]benzodiazepine derivatives, used for treating osteoarthritis, pancreatitis, glomerulonephritis, rheumatoid arthritis, inflammatory bowel disease, Crohn's disease, psoriasis, graft vs host disease, leukemia, septic shock, multiple sclerosis, and inflammatory bowel disease |
| 02/14/2008 | US20080039448 viricides, parasiticide, bactericides, gene therapy and treating cisplatin refractory disease; e.g. 1,1'[[(Propane-1,3-diyl)dioxy]bis(11aS)-11-sulpho-7-methoxy-2-methylidene-1,2,3,10,11,11a-hexahydro-5H-pyrrolo[2,1-c][1,4-benzodiazepin-5-one]] sodium salt |
| 02/14/2008 | US20080039447 CDK-Inhibitory pyrimidines, their production and use as pharmaceutical agents |
| 02/14/2008 | US20080039446 Substituted isoindoles and their use |
| 02/14/2008 | US20080039445 Production method of pyrimidine compounds |
| 02/14/2008 | US20080039444 Antiallergens; antiinflammatory agents; rhinitis |
| 02/14/2008 | US20080039443 Manipulation of brain CDP-diacylglycerol and uses thereof |
| 02/14/2008 | US20080039442 Compounds With Kv4 Ion Channel Activity |
| 02/14/2008 | US20080039441 Storage stability; combination forms with antidepressants, antiinflammatories, serotonin reuptake inhibitors, antiemetics, appetite modulators, antivirals, vasodilators and/or pain relievers |
| 02/14/2008 | US20080039440 such as 6-(6-Amino-pyrimidin-4-yloxy)-3,4-dihydro-2H-quinoline-1-carboxylic acid (3-trifluoromethyl-phenyl)-amide, used for the treatment of leukemia |
| 02/14/2008 | US20080039439 Alpha2C adrenoreceptor agonists |
| 02/14/2008 | US20080039438 1B-Methylcarbapenem Derivative and Process for the Preparation Thereof |
| 02/14/2008 | US20080039437 New Pyridine Analogues III |
| 02/14/2008 | US20080039436 Porphyrin Derivatives And Their Use In Photon Activation Therapy |
| 02/14/2008 | US20080039435 Novel Steroid Agonist For Fxr |
| 02/14/2008 | US20080039434 Treatment of Interstitial Cystitis with Vitamin D Compounds |
| 02/14/2008 | US20080039433 Stabilized Tetracycline Compositions |
| 02/14/2008 | US20080039430 Pharmaceutical Compositions For The Treatment Of Leishmaniasis |
| 02/14/2008 | US20080039429 Sulfonylethyl phosphorodiamidates |
| 02/14/2008 | US20080039428 Antiretroviral combination therapy |
| 02/14/2008 | US20080039427 Method and compositions for treating hematological malignancies |
| 02/14/2008 | US20080039426 2-(4-fluoro-2-methylphenylamino)-1,6-dimethyl-7-[3-(4-methyl-4-oxo-4 lambda 5[1,4]azaphosphinan-1-yl)-propenyl]-1,8-dihydro-imidazo[4,5-h]isoquinolin-9-one; anticancer agents, antiinflammatory agents, antiviral agents, anti-thromboembolic agents, as well as for treating autoimmune disease |
| 02/14/2008 | US20080039425 Methods and Compositions to Reduce Tissue Irritation in Parenteral Formulations |
| 02/14/2008 | US20080039424 Cosmetic composition comprising at least one polysaccharide chosen from lambda-carrageenans in combination with at least one non-ionic surface-active agent chosen from alkylpolyglucosides, and a method for the cosmetic treatment of keratinous fibers therewith |
| 02/14/2008 | US20080039423 Ophthalmic Composition Containing Xanthan Gum and Amino Acid |
| 02/14/2008 | US20080039422 Vitamin B12-Containing Compositions and Methods of Use |
| 02/14/2008 | US20080039421 Molecular Transporters Based On Alditol Or Inositol And Processes For The Preparation Thereof |
| 02/14/2008 | US20080039420 Method for inhibiting NOX1 gene expression |
| 02/14/2008 | US20080039419 Integrin-linked kinase and its uses |
| 02/14/2008 | US20080039418 Compositions and their uses directed to huntingtin |
| 02/14/2008 | US20080039417 Protein Tyrosine Phosphate Mutations in Cancers |
| 02/14/2008 | US20080039416 Methods for Treating Disease by Modulating an Osmotic Stress Pathway |
| 02/14/2008 | US20080039414 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| 02/14/2008 | US20080039413 Novel compositions and methods in cancer |
| 02/14/2008 | US20080039412 Short interfering RNA sequences for use in therapeutic, veterinary, agricultural, diagnostic, target validation, and genomic discovery applications |
| 02/14/2008 | US20080039411 Use Of Resistin Antisense Oligonucleotides And/Or Sirna Molecules In The Treatment Of Rheumatoid Arthritis |
| 02/14/2008 | US20080039410 Inositol 1,4,5-Trisphosphate Receptor Mutants and Uses Thereof |
| 02/14/2008 | US20080039409 Method of Suppressing Cancer |
| 02/14/2008 | US20080039408 Use of Oxypurinol as an Inhibitor of Anti-Neoplastic Agent-Induced Cardiotoxicity |
| 02/14/2008 | US20080039407 Antibiotic and Method of Production Thereof |
| 02/14/2008 | US20080039406 3,6-bridged tylosin derivatives |
| 02/14/2008 | US20080039405 Modification of percutaneous absorption of topically active materials |
| 02/14/2008 | US20080039402 Peptides and Peptidomimetics Binding to Cd23 |
| 02/14/2008 | US20080039401 For allergy such as asthma; modulating interleukin (IL)-9 expression |
| 02/14/2008 | US20080039398 Formulations and methods for treating dry eye |
| 02/14/2008 | US20080039397 Polynucleotide encoding a tropoelastin polypeptide; expression products and hybrid molecules of the derivatives and variants |
| 02/14/2008 | US20080039393 Metal-binding therapeutic peptides |
| 02/14/2008 | US20080039392 CRAC channel and modulator screening methods |
| 02/14/2008 | US20080039391 such as dabigatran etexilate; immobilized patients, congenital heart disease, shunt or catheter thrombosis, pulmonary embolism, stroke in pregnant women |
| 02/14/2008 | US20080039386 vaccines; use for detecting a group B streptococcus serotype III, RDP III-3 strain; drug screen an agent for inhibiting adhesion of a group B streptococcal cell to a host cell |
| 02/14/2008 | US20080039384 Antiangiogenic Peptides |
| 02/14/2008 | US20080039382 Compositions related to pleiotrophin methods and uses thereof |
| 02/14/2008 | US20080039377 Composition Comprising a Jnk Inhibitor and Cyclosporin |
| 02/14/2008 | US20080039374 Cross-lined glycopeptide-cephalosporin antibiotics |
| 02/14/2008 | US20080039369 Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes |
| 02/14/2008 | US20080039367 Medicinal Composition Containing Diabeted Remedy |
| 02/14/2008 | US20080039366 Administering insulin, sodium citrate and phospholipid to respiratory tract |
| 02/14/2008 | US20080039365 Rapid Acting and Long Acting Insulin Combination Formulations |
| 02/14/2008 | US20080039362 Combination drug therapy for reducing scar tissue formation |